TrialClinical genitourinary cancer2016

A Phase II Study of AT-101 to Overcome Bcl-2--Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate Cancer.

Mark N Stein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.